SETD2 deficiency in ccRCC cells is associated with an aberrant accumulation of both free ATG12 and of an additional ATG12-containing complex, distinct from the ATG12–ATG5 conjugate. Here, SETD2 is linked to nonpapillary renal cell carcinoma.